Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 8, 1999, Pages 1905-1911

  Metzler, Bernhard ^a,b,e   Mayr, Manuel ^a,b   Dietrich, Hermann ^b   Singh, Mahauir ^c   Wiebe, Evelyn ^d   Xu, Qingbo ^a   Wick, Georg ^a,b  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d StressGen Biotechnologies Corp   (Canada)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Arteriosclerosis; Heat shock proteins; Immunosuppression; Lymphocytes; Stress proteins

Indexed keywords

FREUND ADJUVANT; HEAT SHOCK PROTEIN 65; MONOCLONAL ANTIBODY CD3; PREDNISOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOSCLEROSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE;

EID: 0032796502     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.8.1905     Document Type: Article

References (44)

1. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulation of T cell, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131-138.
2. Gown AM, Tsukada T, Ross R. Human atherosclerosis. II: immunocytochemical analysis of the cellular composition of human lesions. Am J Pathol. 1986;125:191-207.
3. Munro JM, van der Walt JD, Munro CS, Chalmers JAC, Cox EL. An immunohistochemical analysis of human aortic fatty streaks. Hum Pathol. 1987;18:375-380.
4. Emeson EE, Robertson AL Jr. T lymphocytes in aortic and coronary intimas: their potential role in atherogenesis. Am J Pathol. 1988;130: 369-376.
5. Xu Q, Oberhuher G, Gruschwilz M, Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol. 1990;56:344-359.
6. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989;135:169-175.
7. Miyajima A, Miyatake S, Schreurs J, Vries JD, Arai N, Yokota T, Arai KI. Coordinate regulation of immune and inflammatory responses by T cell derived lymphokines. FASEB J. 1988;2:2462-2471.
8. Fogelman AM, Haberland ME, Edwards PA. Low density lipoprotein receptors and scavenger receptors on monocytes and macrophages: modulation by lymphokines. Lymphokines. 1984;9:363-371.
9. McMurray HF, Parthasarathy S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest. 1993;92:1004-1008.
10. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognizee oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995;25:3893-3897.
11. Huang YH, Ronnelid J, Frostegard J. Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-γ production in lymphocytes from healthy individuals. Arterioscler Thromb. 1995;15: 1577-1583.
12. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherosclerosis. Proc Natl Acad Sci U S A. 1995;92:821-825.
13. Ameli S, Hultgårdh-Nilsson A, Regenström J, Calara F, Yano J, Cercek B, Shah P, Nilsson J. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb. 1996;16:1074-1079.
14. Wick G, Kleindienst R, Dietrich H, Xu Q. Is atherosclerosis an autoimmune disease? Trends Food Sci Technol. 1992;3:114-119.
15. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995;16:27-33.
16. Xu Q, Wick G. The role of heat shock proteins in the protection and pathophysiology of the arterial wall. Mol Med Today. 1996;2:372-379.
17. Wick G, Romen M, Amberger A, Metzler B, Mayr M, Falkensamer G, Xu Q. Atherosclerosis, autoimmunity and the vascular associated lymphoid tissue. FASEB J. 1997;11:1199-1207.
18. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest. 1993;91:2693-2702.
19. Hirsch R, Eckhaus M, Auchincloss H Jr, Sachs DH, Bluestone JA. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. J Immunol. 1988;140:3766-3772.
20. Steinhoff G, Jonker M, Gubernatis G, Wonigeit K, Lauchart W, Bornscheuer A, Pichlmayr R. The course of untreated acute rejection and effect of repeated anti-CD3 monoclonal antibody treatment in rhesus monkey liver transplantation. Transplantation. 1990;49:669-674.
21. Xu Q, Dietrich H, Steiner HJ, Gown AM, Mikuz G, Kaufmann SHE, Wick G. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 1992;12: 789-799.
22. Chatenoud L, Jonker M, Villemain F, Goldstein G, Bach JF. The human immune response to the OKT3 monoclonal antibody is oligoclonal. Science. 1986;232:1406-1408.
23. Jackson S, Chused TM, Wilkinson JM, Leiserson WM, Kindt TJ. Differentiation antigens identify subpopulations of rabbit T and B lymphocytes. J Exp Med. 1983;157:34-46.
24. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechl S, Stulnig T, Luef G, Wick G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet. 1993;341:255-259.
25. Jürgens G, Xu Q, Huber LA, Böck G, Howanietz M, Wick G. Promotion of lymphocyte growth by high density lipoproteins. J Biol Chem. 1989; 264:8549-8556.
26. Traill KN, Böck G, Winter U, Hilchenbach M, Jürgens G, Wick G. Simple method for comparing large numbers of flow cytometry histograms exemplified by analysis of the CD4 antigen and LDL receptor on human peripheral blood lymphocytes. J Histochem Cytochem. 1986;34: 1217-1221.
27. Emeson EE, Shen ML, Bell CGH, Qureshi A. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol. 1996;149:675-685.
28. Roselaar SE, Schonfeld G, Daugherty A. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest. 1995;96:1389-1394.
29. Emeson EE, Shen ML. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. Am J Pathol. 1993;142: 1906-1915.
30. Fyfe AI, Qiao JH, Lusis AJ. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest. 1994;94:2516-2520.
31. Dansky HM, Charlton SA, Harper MH, Smith JD. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1997;94:4642-4646.
32. Dausherty A, Pure E, Delfel-Butteiger D, Chen S, Leferovich J, Roselaar SE, Rader DJ. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest. 1997;100: 1575-1580.
33. Hansson GK, Holm J, Holm S, Fotev Z, Hedrich HJ, Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc Natl of Acad Sci U S A. 1991;88:10530-10534.
34. Zhou X, Stemme S, Hansson GK. Evidence for a local immune response in atherosclerosis: CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol. 1996;149:359-366.
35. Lustig S, Stern N, Golub MS, Eggena P, Barrett J, Lee DBN. Experimental cyclosporin hypertension: characterization of the rat model. Transplant Proc. 1987;21:950-951.
36. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986;55:455-462.
37. Ballantyne DM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM Jr, Young JB. Effects of cyclosporin therapy on plasma lipoprotein levels. JAMA. 1989;262:53-56.
38. Bunchman TE, Brookshire CA. Cyclosporin-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest. 1991;88: 310-314.
39. Xu Q, Luef G, Weimann S, Gupta RS, Wolf H, Wick G. Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler Thromb. 1993;13: 1763-1769.
40. Soltys BJ, Gupta RS. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cels. Exp Cell Res. 1996;10:16-27.
41. Schett G, Xu Q, Amberger A, van der Zee R, Recheis H, Willeit J, Wick G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995;96:2569-2577.
42. Xu Q, Kleindienst R, Schett G, Waitz W, Jindal S, Gupta RS, Dietrich H, Wick G. Regression of atherosclerotic lesions induced by immunization with heat shock protein 65-containing material in normocholesterolemic, but not hypercholesterolemic, rabbits. Atherosclerosis. 1996;123: 145-155.
43. Udelsman R, Blake MJ, Stagg CA, Holbrook NJ. Endocrine control of stress-induced heat shock protein 70 expression in vivo. Surgery. 1994; 115:611-616.
44. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.